article Open AccessTop 1% cited
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Kidney International · 2021 · Vol. 100(4) · pp. S1–S276
Brad H. Rovin✉Sharon G. AdlerJonathan BarrattFrank BridouxKelly A. BurdgeTak Mao ChanH. Terence CookFernando C. FervenzaKeisha L. GibsonRichard J. GlassockDavid JayneVivekanand JhaAdrian LiewZhihong LiuJuan M. Mejía‐ViletCarla NesterJai RadhakrishnanElizabeth M. RaveHeather N. ReichPierre RoncoJan‐Stephan SandersSanjeev SethiYusuke SuzukiSydney TangVladimı́r TesařMarina VivarelliJack F.M. WetzelsJürgen Floege
Renal Diseases and GlomerulopathiesComplement system in diseasesPlatelet Disorders and TreatmentsGuidelineMedicineIntensive care medicineGlomerulonephritisCritical appraisalLupus nephritisNephropathyMembranous nephropathyFocal segmental glomerulosclerosisKidney disease
MeSH terms
Glomerular Filtration RateHumansKidney DiseasesNephrologyRenal Insufficiency, Chronic
Funding
- American Society of Nephrology
- Amgen
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Biogen
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Celgene
- CSL Behring
- BioCryst
- Amicus Therapeutics
- Prothena
- Argenx
- Omeros Corporation
- Apellis Pharmaceuticals
- Natera
- National Institute for Health and Care Research
- University of Leicester
- ZonMw
- Société de Néphrologie
- Astellas Pharma
- MorphoSys
- Idorsia Pharmaceuticals
- InflaRx
- National Institutes of Health
- Genentech
- EMD Serono
- Chugai Pharmaceutical
- Medical Research Council
- National Institute of Diabetes and Digestive and Kidney Diseases
Citations
2,277
FWCI
219.97
field-weighted impact
References
1,062
Percentile
100%
vs. same field & year
Citations per year
Cited by
Rituximab in the treatment of PLA2R-associated membranous nephropathy: Insights from a hospital centre experience
International journal of nephrology research. · 2024 · 0 citations
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Kidney International · 2024 · 6,803 citations
References
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
Arthritis & Rheumatism · 2012 · 1,404 citations
Pathologic classification of focal segmental glomerulosclerosis: a working proposal
American Journal of Kidney Diseases · 2004 · 765 citations
Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD
American Journal of Kidney Diseases · 2008 · 1,027 citations
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
Annals of the Rheumatic Diseases · 2008 · 967 citations
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
British Journal of Haematology · 2012 · 853 citations
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Arthritis & Rheumatism · 2012 · 6,464 citations
Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias
British Journal of Haematology · 2003 · 380 citations
GRADE guidelines 6. Rating the quality of evidence—imprecision
Journal of Clinical Epidemiology · 2011 · 2,634 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.